ArticleFrontiers in cardiovascular medicine2025
In-stent Carlino-a novel bailout for device-uncrossable in-stent chronic total occlusions.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aims: In-stent chronic total occlusion (IS-CTO) remains a challenging subset of coronary interventions, frequently demonstrating device uncrossability despite successful wire crossing. The in-stent Carlino technique can serve as a feasible and safe bailout strategy for device-uncrossable IS-CTOs. Methods: We present two cases of complex IS-CTOs in which successful wire crossing was achieved but device delivery failed despite exhausting appropriate support techniques. In-stent Carlino was performed using controlled contrast injection (0.5 mL) through a wedged microcatheter to create hydraulic plaque modification. Results: Both cases achieved successful device delivery following in-stent Carlino application. The technique facilitated microcatheter advancement and subsequent lesion treatment without complications. The metallic stent framework and dense neoatherosclerotic tissue provided natural containment, preventing extension of the dissection to extra-plaque. Conclusions: In-stent Carlino offers an effective bailout for device-uncrossable IS-CTOs. Compared with conventional Carlino applications, safety is enhanced by the natural containment provided by the stent architecture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.